vs

Side-by-side financial comparison of Arteris, Inc. (AIP) and Entrada Therapeutics, Inc. (TRDA). Click either name above to swap in a different company.

Entrada Therapeutics, Inc. is the larger business by last-quarter revenue ($20.6M vs $20.1M, roughly 1.0× Arteris, Inc.). Arteris, Inc. runs the higher net margin — -42.2% vs -84.4%, a 42.2% gap on every dollar of revenue. On growth, Arteris, Inc. posted the faster year-over-year revenue change (30.0% vs -65.2%). Arteris, Inc. produced more free cash flow last quarter ($3.0M vs $-39.7M). Over the past eight quarters, Arteris, Inc.'s revenue compounded faster (24.7% CAGR vs 6.4%).

Arteris, Inc. is a multinational technology company headquartered in Campbell, California. It develops the network-on-chip (NoC) IP and system-on-chip (SoC) integration automation software that is used to create semiconductor chip and chiplet designs for a variety of devices, particularly in automotive electronics, artificial intelligence, machine learning, enterprise computing, communications, consumer, industrial, and aerospace & defense markets. The company specializes in the development a...

Entrada Therapeutics is a clinical-stage biotechnology firm developing transformative intracellular therapies for serious rare diseases and high-unmet-need disorders. Its pipeline covers neuromuscular, metabolic, and central nervous system segments, serving global patients via healthcare partnerships.

AIP vs TRDA — Head-to-Head

Bigger by revenue
TRDA
TRDA
1.0× larger
TRDA
$20.6M
$20.1M
AIP
Growing faster (revenue YoY)
AIP
AIP
+95.2% gap
AIP
30.0%
-65.2%
TRDA
Higher net margin
AIP
AIP
42.2% more per $
AIP
-42.2%
-84.4%
TRDA
More free cash flow
AIP
AIP
$42.7M more FCF
AIP
$3.0M
$-39.7M
TRDA
Faster 2-yr revenue CAGR
AIP
AIP
Annualised
AIP
24.7%
6.4%
TRDA

Income Statement — Q4 FY2025 vs Q1 FY2025

Metric
AIP
AIP
TRDA
TRDA
Revenue
$20.1M
$20.6M
Net Profit
$-8.5M
$-17.3M
Gross Margin
90.8%
Operating Margin
-42.0%
-106.0%
Net Margin
-42.2%
-84.4%
Revenue YoY
30.0%
-65.2%
Net Profit YoY
-3.7%
-173.8%
EPS (diluted)
$-0.19
$-0.42

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AIP
AIP
TRDA
TRDA
Q4 25
$20.1M
Q3 25
$17.4M
Q2 25
$16.5M
Q1 25
$16.5M
$20.6M
Q4 24
$15.5M
$37.4M
Q3 24
$14.7M
$19.6M
Q2 24
$14.6M
$94.7M
Q1 24
$12.9M
$59.1M
Net Profit
AIP
AIP
TRDA
TRDA
Q4 25
$-8.5M
Q3 25
$-9.0M
Q2 25
$-9.1M
Q1 25
$-8.1M
$-17.3M
Q4 24
$-8.2M
$1.1M
Q3 24
$-7.7M
$-14.0M
Q2 24
$-8.3M
$55.0M
Q1 24
$-9.4M
$23.5M
Gross Margin
AIP
AIP
TRDA
TRDA
Q4 25
90.8%
Q3 25
89.9%
Q2 25
89.4%
Q1 25
90.8%
Q4 24
89.8%
Q3 24
90.1%
Q2 24
90.0%
Q1 24
88.7%
Operating Margin
AIP
AIP
TRDA
TRDA
Q4 25
-42.0%
Q3 25
-50.1%
Q2 25
-50.0%
Q1 25
-46.6%
-106.0%
Q4 24
-45.9%
-15.7%
Q3 24
-53.8%
-110.7%
Q2 24
-51.1%
56.4%
Q1 24
-70.5%
35.7%
Net Margin
AIP
AIP
TRDA
TRDA
Q4 25
-42.2%
Q3 25
-51.6%
Q2 25
-55.3%
Q1 25
-49.1%
-84.4%
Q4 24
-53.0%
3.0%
Q3 24
-52.2%
-71.7%
Q2 24
-57.2%
58.1%
Q1 24
-72.6%
39.7%
EPS (diluted)
AIP
AIP
TRDA
TRDA
Q4 25
$-0.19
Q3 25
$-0.21
Q2 25
$-0.22
Q1 25
$-0.20
$-0.42
Q4 24
$-0.19
$-0.20
Q3 24
$-0.20
$-0.35
Q2 24
$-0.22
$1.55
Q1 24
$-0.25
$0.68

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AIP
AIP
TRDA
TRDA
Cash + ST InvestmentsLiquidity on hand
$33.9M
$67.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$-14.6M
$417.3M
Total Assets
$115.0M
$486.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AIP
AIP
TRDA
TRDA
Q4 25
$33.9M
Q3 25
$39.0M
Q2 25
$38.0M
Q1 25
$42.3M
$67.8M
Q4 24
$43.8M
$101.2M
Q3 24
$48.7M
$78.0M
Q2 24
$45.8M
$185.3M
Q1 24
$44.8M
$68.4M
Stockholders' Equity
AIP
AIP
TRDA
TRDA
Q4 25
$-14.6M
Q3 25
$-11.4M
Q2 25
$-7.5M
Q1 25
$-4.8M
$417.3M
Q4 24
$-1.2M
$428.7M
Q3 24
$2.2M
$422.4M
Q2 24
$5.3M
$429.9M
Q1 24
$9.5M
$269.4M
Total Assets
AIP
AIP
TRDA
TRDA
Q4 25
$115.0M
Q3 25
$107.7M
Q2 25
$106.9M
Q1 25
$98.3M
$486.5M
Q4 24
$106.1M
$526.3M
Q3 24
$97.7M
$554.6M
Q2 24
$96.4M
$582.0M
Q1 24
$101.4M
$510.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AIP
AIP
TRDA
TRDA
Operating Cash FlowLast quarter
$3.2M
$-38.5M
Free Cash FlowOCF − Capex
$3.0M
$-39.7M
FCF MarginFCF / Revenue
15.1%
-192.9%
Capex IntensityCapex / Revenue
0.7%
5.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$5.3M
$-58.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AIP
AIP
TRDA
TRDA
Q4 25
$3.2M
Q3 25
$3.2M
Q2 25
$-2.5M
Q1 25
$2.9M
$-38.5M
Q4 24
$-2.6M
$-31.6M
Q3 24
$1.1M
$-24.3M
Q2 24
$311.0K
$39.8M
Q1 24
$477.0K
$-25.5M
Free Cash Flow
AIP
AIP
TRDA
TRDA
Q4 25
$3.0M
Q3 25
$2.5M
Q2 25
$-2.8M
Q1 25
$2.7M
$-39.7M
Q4 24
$-2.7M
$-32.2M
Q3 24
$1.1M
$-24.9M
Q2 24
$264.0K
$38.8M
Q1 24
$281.0K
$-26.4M
FCF Margin
AIP
AIP
TRDA
TRDA
Q4 25
15.1%
Q3 25
14.2%
Q2 25
-17.2%
Q1 25
16.2%
-192.9%
Q4 24
-17.3%
-86.2%
Q3 24
7.4%
-127.3%
Q2 24
1.8%
41.0%
Q1 24
2.2%
-44.6%
Capex Intensity
AIP
AIP
TRDA
TRDA
Q4 25
0.7%
Q3 25
4.1%
Q2 25
2.2%
Q1 25
1.1%
5.6%
Q4 24
0.3%
1.7%
Q3 24
0.2%
3.3%
Q2 24
0.3%
1.1%
Q1 24
1.5%
1.4%
Cash Conversion
AIP
AIP
TRDA
TRDA
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-27.94×
Q3 24
Q2 24
0.72×
Q1 24
-1.09×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AIP
AIP

License And Maintenance$17.5M87%
Variable Royalties And Other$2.6M13%

TRDA
TRDA

Segment breakdown not available.

Related Comparisons